Cross-Species Evolution of Synthetic AAV Strains for Clinical Translation
Conferences
Gonzalez, TJ; Havlik, LP; Fanous, M; Simon, K; Edwards, L; Kwon, J; Stafford, VG; Devlin, G; ElMallah, MK; Gersbach, CA; Piedrahita, J; Asokan, A
Published in: MOLECULAR THERAPY
April 28, 2020
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
MOLECULAR THERAPY
EISSN
1525-0024
ISSN
1525-0016
Publication Date
April 28, 2020
Volume
28
Issue
4
Start / End Page
12 / 13
Related Subject Headings
- Biotechnology
- 3206 Medical biotechnology
- 3202 Clinical sciences
- 3105 Genetics
Citation
APA
Chicago
ICMJE
MLA
NLM
Gonzalez, T. J., Havlik, L. P., Fanous, M., Simon, K., Edwards, L., Kwon, J., … Asokan, A. (2020). Cross-Species Evolution of Synthetic AAV Strains for Clinical Translation. In MOLECULAR THERAPY (Vol. 28, pp. 12–13).
Gonzalez, Trevor J., L Patrick Havlik, Marco Fanous, Katherine Simon, Laura Edwards, Jennifer Kwon, V Grace Stafford, et al. “Cross-Species Evolution of Synthetic AAV Strains for Clinical Translation.” In MOLECULAR THERAPY, 28:12–13, 2020.
Gonzalez TJ, Havlik LP, Fanous M, Simon K, Edwards L, Kwon J, et al. Cross-Species Evolution of Synthetic AAV Strains for Clinical Translation. In: MOLECULAR THERAPY. 2020. p. 12–3.
Gonzalez, Trevor J., et al. “Cross-Species Evolution of Synthetic AAV Strains for Clinical Translation.” MOLECULAR THERAPY, vol. 28, no. 4, 2020, pp. 12–13.
Gonzalez TJ, Havlik LP, Fanous M, Simon K, Edwards L, Kwon J, Stafford VG, Devlin G, ElMallah MK, Gersbach CA, Piedrahita J, Asokan A. Cross-Species Evolution of Synthetic AAV Strains for Clinical Translation. MOLECULAR THERAPY. 2020. p. 12–13.
Published In
MOLECULAR THERAPY
EISSN
1525-0024
ISSN
1525-0016
Publication Date
April 28, 2020
Volume
28
Issue
4
Start / End Page
12 / 13
Related Subject Headings
- Biotechnology
- 3206 Medical biotechnology
- 3202 Clinical sciences
- 3105 Genetics